Wenxin Wang

TL;DR: Clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D is provided, associated with markedly lower mortality compared to individuals with poorly controlled BG during hospitalization.

TL;DR: Wang et al. as discussed by the authors evaluated the epidemiology, risk factors, complications, and management of nonalcoholic fatty liver disease in China through a systematic review and meta-analysis, and found that NAFLD is positively correlated with the incidence of extrahepatic tumors, diabetes, cardiovascular disease and metabolic syndrome.

TL;DR: Wang et al. as mentioned in this paper summarized eight epidemiological features of NAFLD in China over the past two decades using systematic review and meta-analysis methodology. And they revealed that there is a strong ethnic difference in body mass index (BMI) and genetic risk of nonalcoholic fatty liver disease compared with the US population.

TL;DR: Investigation of the underlying mechanisms revealed that TRIM8 directly binds to and ubiquitinates transforming growth factor‐beta–activated kinase 1, thus promoting its phosphorylation and the activation of downstream c‐Jun N‐terminal kinase/p38 and nuclear factor κB signaling.

TL;DR: In this article, the authors analyzed the global disease burden of IHD and 15 associated general risk factors from 1990 to 2019 by applying the methodology framework of the Global Burden of Disease Study.